Lupin signs second partnership for its oncology pipeline, this time with German drug maker BI
Posted by
www.biotecnika.org
BI and Lupin will together develop and commercialise a new drug called
MEK inhibitor that will target specific cancer cells and potentially
treat patients of skin and stomach cancer.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-signs-second-partnership-for-its-oncology-pipeline-this-time-with-german-drug-maker-bi/articleshow/70978748.cms
Subscribe to:
Post Comments (Atom)
Post a Comment